GeneReach Biotechnology (4171) — Free Cash Flow Generation Index
GeneReach Biotechnology (4171) has a Free Cash Flow Generation Index of -0.29x as of June 2026. Free cash flow of NT$-1.85 Million represents 0% of operating cash flow (NT$6.28 Million). Explore 4171 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
GeneReach Biotechnology Free Cash Flow Generation Index (2018–2022)
Historical FCF Generation Index trend for GeneReach Biotechnology across 4 annual periods. For the full cash flow conversion analysis, see how efficiently does GeneReach Biotechnology generate cash.
Annual Free Cash Flow Generation for GeneReach Biotechnology (2018–2022)
Year-by-year Free Cash Flow Generation Index for GeneReach Biotechnology. Check GeneReach Biotechnology cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.87x | NT$312.73 Million | NT$357.63 Million | NT$44.90 Million | ▼ -8.4% |
| 2021 | 0.95x | NT$333.20 Million | NT$348.99 Million | NT$15.79 Million | ▲ +54.5% |
| 2020 | 0.62x | NT$104.95 Million | NT$169.82 Million | NT$64.87 Million | ▲ +3.3% |
| 2018 | 0.60x | NT$3.44 Million | NT$5.74 Million | NT$2.31 Million | — |